Morning Market Losers
December 04, 2014 at 09:52 AM EST
Kindred Biosciences (NASDAQ: KIN) shares slipped 31.41% to $6.34 after the company reported that it has decided to stop its Atokin ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.